Fidelity Investments’s Generation Bio GBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,617
Closed -$14.9K 5481
2025
Q4
$14.9K Sell
2,617
-10,414
-80% -$58.8K ﹤0.01% 4590
2025
Q3
$79.8K Sell
13,031
-221,531
-94% -$1.15M ﹤0.01% 3757
2025
Q2
$751K Sell
234,562
-240,680
-51% -$927K ﹤0.01% 2822
2025
Q1
$1.92M Buy
475,242
+12,637
+3% +$88.8K ﹤0.01% 2455
2024
Q4
$4.9M Sell
462,605
-69,422
-13% -$1.24M ﹤0.01% 2157
2024
Q3
$13.1M Buy
532,027
+1,566
+0.3% +$41.4K ﹤0.01% 1841
2024
Q2
$15M Sell
530,461
-2,965
-0.6% -$96.3K ﹤0.01% 1749
2024
Q1
$21.7M Sell
533,426
-1,814
-0.3% -$42.7K ﹤0.01% 1617
2023
Q4
$8.83M Sell
535,240
-308,037
-37% -$5.37M ﹤0.01% 1884
2023
Q3
$32M Sell
843,277
-18,980
-2% -$899K ﹤0.01% 1420
2023
Q2
$47.4M Sell
862,257
-32,729
-4% -$1.5M ﹤0.01% 1297
2023
Q1
$38.5M Buy
894,986
+3,653
+0.4% +$177K ﹤0.01% 1354
2022
Q4
$35M Buy
891,333
+6,165
+0.7% +$324K ﹤0.01% 1399
2022
Q3
$47M Buy
885,168
+28,874
+3% +$1.81M ﹤0.01% 1265
2022
Q2
$56.2M Buy
856,294
+1,217
+0.1% +$79.6K 0.01% 1204
2022
Q1
$62.8M Buy
855,077
+1,431
+0.2% +$82.9K 0.01% 1301
2021
Q4
$60.4M Buy
853,646
+1,937
+0.2% +$338K ﹤0.01% 1349
2021
Q3
$214M Buy
851,709
+2,207
+0.3% +$528K 0.02% 779
2021
Q2
$229M Buy
849,502
+3,091
+0.4% +$925K 0.02% 762
2021
Q1
$241M Buy
846,411
+128,325
+18% +$41.1M 0.02% 709
2020
Q4
$204M Sell
718,086
-19,252
-3% -$6.18M 0.02% 739
2020
Q3
$220M Sell
737,338
-49
-0% -$11.7K 0.02% 603
2020
Q2
$144M Buy
+737,387
New +$164M 0.02% 730

Other funds holding GBIO

Fidelity Investments's GBIO Position: Q1 2026 in Review

Fidelity Investments sold out of Generation Bio (GBIO) in Q1 2026, closing a stake of 2,617 shares — an estimated $14.9K sold.

Fidelity Investments first reported a position in GBIO in Q2 2020 and held it in 23 quarters. The position peaked at $241M in Q1 2021. 2 funds tracked by Wall St. Rank hold GBIO as of Q1 2026.

  • Fidelity Investments reported no remaining Generation Bio position as of Q1 2026 after selling out during the quarter.
  • Fidelity Investments sold 2,617 Generation Bio shares in Q1 2026, an estimated $14.9K.
  • Fidelity Investments first reported a position in Generation Bio in Q2 2020 and held it in 23 quarters.
  • Fidelity Investments's Generation Bio position peaked at $241M in Q1 2021.
  • 2 funds tracked by Wall St. Rank held Generation Bio as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.